Metabolism of [6]-Shogaol in Mice and in Cancer Cells

Huadong Chen,Lishuang Lv,Dominique Soroka,Renaud F. Warin,Tiffany A. Parks,Yuhui Hu,Yingdong Zhu,Xiaoxin Chen,Shengmin Sang
DOI: https://doi.org/10.1124/dmd.111.043331
2012-01-01
The FASEB Journal
Abstract:Ginger has received extensive attention because of its antioxidant, anti‐inflammatory, and antitumor activities. However, the metabolic fate of its major components is still unclear. In the present study, the metabolism of [6]‐shogaol, one of the major active components in ginger, in mice and in cancer cells (HCT‐116, HT‐29, H‐1299, and CL‐13), was examined for the first time. Our results indicated that [6]‐shogaol is extensively metabolized in human cancer cells and in mice and the mercapturic acid pathway is one of the major biotransformation pathways of [6]‐shogaol. The major phase I and phase II metabolites of [6]‐shogaol were purified from mouse fecal samples and identified using 1D and 2D NMR spectra as well as tandem mass spectra (MSn, n=2–3). The effects of the major metabolites of [6]‐shogaol on the growth inhibition and induction of apoptosis on human lung and colon cancer cells will also be discussed. This work was supported by NIH Grant CA138277 and CA138277S1 to S. Sang.
What problem does this paper attempt to address?